1488
E. Krawczyk et al. / Tetrahedron: Asymmetry 23 (2012) 1480–1489
7a 1H NMR (200 MHz, CDCl3) d 7.50–7.42 (m, 2H, Ph), 7.38–7.30
(m, 3H, Ph), 4.05, 4.06 (d sextet, 4H, J 7.2, 1.2 Hz,, OCH2CH3), 3.01
(dq, 1H, J 5.3,1.8 Hz, POCOC(H), 1.66 (d, 3H, J 5.3 Hz, CH3), 1.24,
1.14 (2t, 6H, J 7.2 Hz, OCH2CH3); 31P NMR (81 MHz, CDCl3) d
ꢁ3.9. Epoxide 7a was hydrolyzed with CF3C(O)OH in Et2O/H2O
solution at 0 °C14b to the title compound 6a. The enantiomeric ex-
cess was determined by HPLC (Chiracel OD-H), (R)-(+)-6a, entry 6:
5% i-PrOH in hexane, 0.4 mL/min; tR [min] 18.8 (S), tR [min] 21.1
7.1 Hz, CH2), 0.92 (t, 3H J 7.0 Hz, CH3); 31P NMR (81 MHz, CDCl3)
d ꢁ14.8. Epoxide 7h was hydrolyzed with CF3C(O)OH in Et2O/
H2O solution at 0 °C14b to the title compound 6f. The enantiomeric
excess of 6f was determined by HPLC (Chiracel OD-H), 3% i-PrOH in
hexane, 0.3 mL/min; tR [min] 19.3 (S), tR [min] 25.8 (R);
½
a 2D0
ꢂ
¼ ꢁ14:1 (c 0.34, CHCl3); lit.14b (R)-(+)-6f: ½a 2D0
¼ þ17:3 (c
ꢂ
1.3, CHCl3), ee = 68% from 4h.
(R); ½a 2D0
ꢂ
¼ þ73:3 (c 0.4, CHCl3).
4.6. General epoxidation procedure Method B (under catalytic
conditions). Preparation of (R)-(+)-3-hydroxy-2,3-dihydro-4H-
chromen-4-one 9b from 5b
4.5.6. (S)-(ꢁ)-2-Hydroxy-1-phenyl-1-propan-1-one 6a14b,26
(Table 2, entry 7)
Epoxide 7b was prepared according to the general epoxidation
procedure (method A) from phosphoric acid diphenyl ester 1-phe-
nyl-propenyl ester 4b and dioxirane 3 to provide crude compound
7b. 1H NMR (200 MHz, CDCl3) d 7.54–7.06 (m, 15H, Ph, OPh), 3.09
(dq, 1H, J 5.3,1.8 Hz, POCOC(H), 1.62 (d, 3H, J 5.3 Hz, CH3); 31P NMR
The mixture of buffer (0.05 M Na2B4O7 10 H2O in 4 ꢃ 10ꢁ4
aqueous Na2(EDTA), 10 mL), enol phosphate 5b (284 mg, 1 mmol),
Bu4N+OHꢁ (cat.), and ketone 2 in acetonitrile (15 mL) was cooled to
0 °C with stirring. Next, a solution of Oxone (0.85 g, 1.38 mmol) in
aqueous Na2(EDTA) (4 ꢃ 10ꢁ4 M, 8 mL) and a solution of K2CO3
(0.8 g, 5.8 mmol) in water (7 mL) were placed in two separate fun-
nels. These solutions were added dropwise for 1.5 h to the reaction
mixture (pH ꢄ10) after which the reaction was quenched by the
addition of hexane and water. The mixture was extracted with
hexane (2 ꢃ 10 mL) and then with diethyl ether (2 ꢃ 20 mL),
washed with brine, and dried over Na2SO4. After evaporation of
the solvents, the crude mixture was analyzed by 1H and 31P
NMR. Separation of the mixture by flash chromatography (Hex-
M
(81 MHz, CDCl3)
d
ꢁ15.1. Epoxide 7b was hydrolyzed with
CF3C(O)OH in Et2O/H2O solution at 0 °C14b to the title compound
6a. The enantiomeric excess was determined by HPLC (Chiracel
OD-H), (S)-(ꢁ)-6a, entry 7: 4% i-PrOH in hexane, 0.4 mL/min; tR
[min] 17.3 (S), tR [min] 19.3 (R); ½a D20
¼ ꢁ55:2. (c 1, CHCl3).
ꢂ
4.5.7. (R)-(+)-2-Hydroxy-1-phenyl-1-pentan-1-one 6f
29,30(Table 2, entry 8)
Epoxide 7f was prepared according to the general epoxidation
procedure (method A) from phosphoric acid diisopropyl ester 1-
phenyl-pent-1-enyl ester 4f and dioxirane 3 to provide crude com-
pound 7f, 1H NMR (200 MHz, CDCl3) d 7.50–7.45 (m, 3H, Ph), 7.36–
7.28 (m, 2H, Ph), 4.62 (m, 2H, OCH(CH3)2), 2.85 (br t, 1H, J 6.0 Hz,
(POCOC(H)), 1.82–1.74 (m, 2H, CH2), 1.53–1.46 (m, 2H, CH2), 1.26
(br t, 6H, J 6.0 Hz, OCH(CH3)2Hz), 0.93 (t, 3H, J 7.0 Hz, CH3); 31P
NMR (81 MHz, CDCl3) d ꢁ6.2. Epoxide 7f was hydrolyzed with
CF3C(O)OH in Et2O/H2O solution at 0 °C14b to the title compound
6f (colorless liquid). The enantiomeric excess of 6f was determined
by HPLC (Chiracel OD-H), 3% i-PrOH in hexane, 0.3 mL/min; tR
ane/EtOAc 9/1) gave
a
-hydroxy chromanone 9b as a white solid
(65 mg, 40% yield). ½a D20
ꢂ ¼ þ30 (c 0.2, CHCl3), Rf (50% EtOAC/hex-
ane) 0.7; mp 58–60 °C; Enantiomeric excess was determined by
HPLC, Chiracel OD-H: (R)-(+)-9b, ee 83%, HPLC conditions: (Table 2,
entry 3) 0.7% i-PrOH in hexane, 0.5 mL/min; tR [min] 33.9(R), tR
[min] 40.1 (S).
Acknowledgments
Financial support by the Ministry of Science and Higher Educa-
tion of Poland (Grant No. N204 517839; 2010–2013) is gratefully
acknowledged. The authors thank Professor P. Kiełbasinski for
[min] 19.0 (S), tR [min] 25.5 (R); ½a D20
ꢂ
¼ þ11:0. (c 0.2, CHCl3); lit.14b
´
(R)-(+)-6f: ½a 2D0
ꢂ
¼ þ17:3 (c 1.3, CHCl3), ee = 68% from 4h; lit.31 (R)-
helpful discussion.
acetate derivative of 6f ½a D20
¼ ꢁ2:3 (c 0.5, acetone).
ꢂ
References
4.5.8. (S)-(ꢁ)-2-Hydroxy-1-phenyl-1-pentan-1-one 6f29,30
(Table 2, entry 9)
1. (a)Total Synthesis of Natural Products: The Chiron Approach; Hanessian, S.,
Epoxide 7g was prepared according to the general epoxidation
procedure (method A) from phosphoric acid bis-(4-chloro-phenyl)
ester 1-phenyl-pent-1-enyl ester 4g and dioxirane 3 to provide
crude compound 7g 1H NMR (200 MHz, CDCl3) d 7.35–7.31 (m,
5H, Ph), 7.22–7.19 (m, 4H, 4-ClC6H4), 6.95 (d, 4H, J 8.6 Hz, 4-
ClC6H4), 3.30 (br s, 1H, (POCOC(H)), 2.08 (dq, 2H, J 7.6, 2.5 Hz,
CH2), 1.43 (dd, 2H, J 7.1, 2.5 Hz, CH2), 0.77 (t, 3H J 7.1 Hz, CH3);
31P NMR (81 MHz, CDCl3) d ꢁ15.9. Epoxide 7g was hydrolyzed with
CF3C(O)OH in Et2O/H2O solution at 0 °C14b to the title compound
6f. The enantiomeric excess of 6f was determined by HPLC (Chira-
cel OD-H), 3% i-PrOH in hexane, 0.3 mL/min; tR [min] 19.7 (S), tR
Ed.; Pergamon: New York, 1983. Chapter 2; (b)a-Hydroxy Acids in
Enantioselective Synthesis; Coppola, G. M., Schuster, H. F., Eds.; Wiley-VCH:
Weinheim, 1997.
2. (a) Davis, F. A.; Chen, B.-C. Chem. Rev. 1992, 92, 919; (b) Enders, D.; Breuer, K. In
Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., Yammamoto, H.,
Eds.; Berlin: Springer, 1999; Vol. 2, pp 1093–1102.
3. (a) Hashiyama, T.; Morikawa, K.; Sharpless, K. B. J. Org. Chem. 1992, 57, 5067;
(b) Morikawa, K.; Park, J.; Anderson, P. G.; Hashiyama, T.; Sharpless, K. B. J. Am.
Chem. Soc. 1993, 115, 8463.
4. (a) Adam, W.; Fell, R. T.; Stegmann, V. R.; Saha-Möller, C. R. J. Am. Chem. Soc.
1998, 120, 708; (b) Adam, W.; Fell, R. T.; Mock-Knoblauch, C.; Saha-Möller, C. R.
Tetrahedron Lett. 1996, 37, 6531; (c) Fukuda, T.; Katsuki, T. Tetrahedron Lett.
1996, 37, 4389.
5. (a) Berkessel, A.; Schroder, M.; Sklorz, Ch. A.; Tabanella, S.; Vogl, N.; Lex, J.;
Neudorfl, J. M. J. Org. Chem. 2004, 69, 3050; (b) Berkessel, A.; Brandenburg, M.;
Leitterstorf, E.; Frey, J.; Lex, J.; Schafer, M. Adv. Synth. Catal. 2007, 349, 2385.
6. Wang, Z.-X.; Tu, Y.; Frohn, M.; Zhang, J.-R.; Shi, Y. J. Am. Chem. Soc. 1997, 119,
11224. and references therein.
7. (a) Zhu, Y.; Tu, Y.; Yu, H.; Shi, Y. Tetrahedron Lett. 1998, 39, 7819; (b) Zhu, Y.;
Shu, L.; Tu, Y.; Shi, Y. J. Org. Chem. 1818, 2001, 66; (c) Shi, Y. Acc. Chem. Res. 2004,
37, 488. and references therein..
8. (a) Tian, H.; She, X.; Shu, L.; Yu, H.; Shi, Y. J. Am. Chem. Soc. 2000, 122, 11551; (b)
Shu, L.; Shi, Y. Tetrahedron Lett. 2004, 45, 8115; (c) Shu, L.; Wang, P.; Gan, Y.;
Shi, Y. Org. Lett. 2003, 3, 293; (d) Shen, Y.-M.; Wang, B.; Shi, Y. Tetrahedron Lett.
2006, 47, 5455; (e) Wang, B.; Shen, Y.-M.; Shi, Y. J. Org. Chem. 2006, 71, 9519; (f)
Burke, Ch. P.; Shi, Y. J. Org. Chem. 2007, 72, 4093.
[min] 27.3 (R); ½a D20
ꢂ
¼ ꢁ10:2. (c 0.14, CHCl3); lit.14b (S)-(ꢁ)-6f:
½
a 2D0
ꢂ
¼ ꢁ19:9 (c 2.4, CHCl3), ee = 88% from 4f; lit.30 (S)-acetate
derivative of 6f ½a D20
ꢂ
¼ þ1:9 (c 0.8, acetone).
4.5.9. (S)-(ꢁ)-2-Hydroxy-1-phenyl-1-pentan-1-one 6f29,30
(Table 2, entry 10)
Epoxide 7h was prepared according to the general epoxidation
procedure (method A) from phosphoric acid bis-(4-methoxy-phe-
nyl) ester 1-phenyl-pent-1-enyl ester 4h and dioxirane 3 to pro-
vide crude compound 7h. 1H NMR (200 MHz, CDCl3) d 7.48–7.37
(m, 2H, Ph), 7.30–7.28 (m, 3H, Ph), 7.07–6.92 (m, 4H, 4-MeOC6H4),
6.87–6.73 (m, 4H, 4-MeOC6H4), 3.6 (s, 6H, MeO), 2.94 (dt, 1H, J 6.0,
1.9 Hz, (POCOC(H)), 1.80 (q, 2H, J 7.1 Hz, CH2), 1.52 (br t, 2H, J
9. Koprowski, M.; Krawczyk, E.; Skowron´ ska, A.; McPartlin, M.; Choi, N.;
Radojevic, S. Tetrahedron 2001, 57, 1105.
10. Skowron´ ska, A.; Koprowski, M.; Krawczyk, E. Phosphorus, Sulfur Silicon 1877,
2002, 177.
11. Peter, G. D.; Carreira, E. Bioorg. Med. Chem. Lett. 1995, 5, 2347.